ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Calidi Biotherapeutics Inc

Calidi Biotherapeutics Inc (CLDI)

0.8346
-0.0593
(-6.63%)
終了 1月22日 6:00AM
0.8771
0.0425
(5.09%)
取引時間後: 9:58AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.8771
買値
-
売値
-
出来高
522,038
0.8108 日の範囲 0.9009
0.73 52 週間の範囲 16.80
時価総額
前日終値
0.8939
始値
0.9009
最終取引時間
財務取引量
US$ 441,109
VWAP
0.844975
平均取引量 (3 か月)
1,905,922
発行済株式数
13,078,022
配当利回り
-
PER
-0.37
1 株当たり利益 (EPS)
-2.23
歳入
-
純利益
-29.22M

Calidi Biotherapeutics Inc について

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Calidi Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the アメリカ証券取引所 with ticker CLDI. The last closing price for Calidi Biotherapeutics was US$0.89. Over the last year, Calidi Biotherapeutics shares have traded in a share price range of US$ 0.73 to US$ 16.80.

Calidi Biotherapeutics currently has 13,078,022 shares in issue. The market capitalisation of Calidi Biotherapeutics is US$11.69 million. Calidi Biotherapeutics has a price to earnings ratio (PE ratio) of -0.37.

CLDI 最新ニュース

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data supporting RTNova (CLD-400), the company’s...

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

- RTNova, an innovative systemic antitumor enveloped virotherapy, unlocks new possibilities in cancer therapy - RTNova addresses challenges posed by untargetable and untreatable metastatic...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0679-7.185185185190.9450.94710.839409280.90639147CS
4-0.4929-35.97810218981.371.530.81812349711.18195695CS
12-0.2629-23.06140350881.143.890.81819059222.07151765CS
26-1.0129-53.59259259261.893.890.7310061441.93710925CS
52-10.3229-92.1687511.216.80.7310398532.57505104CS
156-44.2229-98.05521064345.1500.737848143.03453305CS
260-44.2229-98.05521064345.1500.737848143.03453305CS

CLDI - Frequently Asked Questions (FAQ)

What is the current Calidi Biotherapeutics share price?
The current share price of Calidi Biotherapeutics is US$ 0.8771
How many Calidi Biotherapeutics shares are in issue?
Calidi Biotherapeutics has 13,078,022 shares in issue
What is the market cap of Calidi Biotherapeutics?
The market capitalisation of Calidi Biotherapeutics is USD 11.69M
What is the 1 year trading range for Calidi Biotherapeutics share price?
Calidi Biotherapeutics has traded in the range of US$ 0.73 to US$ 16.80 during the past year
What is the PE ratio of Calidi Biotherapeutics?
The price to earnings ratio of Calidi Biotherapeutics is -0.37
What is the reporting currency for Calidi Biotherapeutics?
Calidi Biotherapeutics reports financial results in USD
What is the latest annual profit for Calidi Biotherapeutics?
The latest annual profit of Calidi Biotherapeutics is USD -29.22M
What is the registered address of Calidi Biotherapeutics?
The registered address for Calidi Biotherapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Calidi Biotherapeutics website address?
The website address for Calidi Biotherapeutics is www.calidibio.com
Which industry sector does Calidi Biotherapeutics operate in?
Calidi Biotherapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TPETTrio Petroleum Corp
US$ 2.64
(48.31%)
45.75M
HUSAHouston American Energy Corp
US$ 2.36
(41.32%)
36.4M
CHROChannel Therapeutics Corporation
US$ 2.6411
(39.01%)
32.13M
EONREON Resources Inc
US$ 1.33
(30.39%)
133.23M
RHERegional Health Properties Inc
US$ 2.84
(24.02%)
250.49k
SCPXScorpius Holdings Inc
US$ 0.301
(-95.93%)
1.08M
ROLRHigh Roller Technologies Inc
US$ 4.77
(-18.98%)
47.13k
AEONAEON Biopharma Inc
US$ 0.129199
(-16.10%)
12M
BWETAmplify Commodity Trust
US$ 10.4273
(-13.23%)
2.25k
ETUT Rex 2X Long Ether Daily Target ETF
US$ 36.63
(-11.80%)
36k
EONREON Resources Inc
US$ 1.33
(30.39%)
133.45M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12.685
(-3.39%)
66.6M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 33.69
(3.69%)
60.46M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.79
(-2.53%)
52.66M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.13
(1.43%)
48.58M

CLDI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock